Silence Therapeutics (SLN) Stock Chart & Stock Price History $5.52 +0.03 (+0.55%) Closing price 04:00 PM EasternExtended Trading$5.54 +0.03 (+0.45%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Silence Therapeutics Stock Price Performance The Silence Therapeutics (SLN) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 64.82%, with a year-to-date return of -19.77%. In the past month, the stock has decreased 8.61%, reflecting recent market activity. As of the latest close, Silence Therapeutics traded at $5.49 with a market cap of and volume of 92,097 shares. Receive SLN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Silence Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-5.64%1 Month Performance-8.61%3 Month Performance+26.32%Year-To-Date Performance-19.77%1 Year Performance-64.82% SLN Stock Chart for Monday, August, 18, 2025 SLN Chart by TradingView Silence Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/15/2025$5.63$5.49-2.49%$5.91$5.4492,097 shs$0.0008/14/2025$5.85$5.63-3.76%$5.95$5.5537,199 shs$168.51 million08/13/2025$5.59$5.85+4.65%$6.21$5.47111,564 shs$0.0008/12/2025$5.09$5.59+9.82%$5.67$4.8095,430 shs$0.0008/11/2025$5.04$5.09+0.99%$5.09$4.43118,103 shs$152.34 million08/08/2025$5.38$5.04-6.32%$5.50$5.0269,069 shs$0.0008/07/2025$5.32$5.38+1.13%$5.46$4.86122,613 shs$161.02 million08/06/2025$5.61$5.32-5.17%$5.64$5.2749,725 shs$0.0008/05/2025$5.95$5.61-5.71%$5.95$5.4375,358 shs$0.0008/04/2025$6.17$5.95-3.57%$6.26$5.7553,448 shs$178.08 million Get the Latest News and Ratings for SLN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Silence Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/01/2025$6.16$6.17+0.16%$6.28$6.0762,280 shs$184.67 million07/31/2025$6.15$6.16+0.16%$6.40$5.8268,140 shs$0.0007/30/2025$6.20$6.15-0.81%$6.33$6.0168,750 shs$0.0007/29/2025$5.92$6.20+4.73%$6.28$5.8199,233 shs$185.57 million07/28/2025$6.34$5.92-6.62%$6.50$5.8865,724 shs$0.0007/25/2025$6.28$6.34+0.96%$6.48$6.2035,521 shs$0.0007/24/2025$6.15$6.28+2.11%$6.30$6.0353,528 shs$0.0007/23/2025$6.25$6.15-1.60%$6.40$5.81122,459 shs$184.07 million07/22/2025$6.17$6.25+1.30%$6.30$5.7662,580 shs$0.0007/21/2025$6.04$6.17+2.15%$6.19$5.7799,451 shs$0.0007/18/2025$6.22$6.04-2.89%$6.30$5.9254,968 shs$0.0007/17/2025$6.35$6.22-2.05%$6.49$6.1054,437 shs$186.17 million Related Companies ATNFW Stock Price Chart LBPSW Stock Price Chart AEHAW Stock Price Chart AIMDW Stock Price Chart ALVOW Stock Price Chart ARAV Stock Price Chart ACABW Stock Price Chart BFRIW Stock Price Chart BTMDW Stock Price Chart BCTXW Stock Price Chart Receive SLN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Silence Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SLN) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredTrump’s SHOCKING Plan to Create MASSIVE Wealth for AmericansJames Altucher says Donald Trump just made a move so surprising, it could go down as the most lucrative presid...Paradigm Press | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredAmericans are rushing into gold (but not billionaires!)Billionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scra...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silence Therapeutics PLC Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Silence Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access